News

Article

Study: Aromatherapy decreased postoperative patient anxiety and pain associated with oculoplastic surgery

Author(s):

Key Takeaways

  • Aromatherapy significantly reduced postoperative anxiety and pain in patients undergoing oculoplastic procedures with monitored anesthesia care sedation.
  • The study involved 60 patients, with 32 receiving aromatherapy and 28 receiving placebo, showing lower anxiety and pain scores in the aromatherapy group.
SHOW MORE

The investigators conducted a randomized controlled trial of 60 patients who underwent monitored anesthesia care sedation for oculoplastic procedures from August 2018 to November 2020.

(Image Credit: AdobeStock/puhimec)

(Image Credit: AdobeStock/puhimec)

Aromatherapy may be a useful addition to help patients who are undergoing oculoplastic procedures under monitored anesthetic sedation. In this study, the use of aromatherapy resulted in lower postoperative anxiety and pain scores,1 according to patient reporting.

First author Michael Chang, MD, from the Department of Ophthalmology and Visual Sciences, West Virginia University School of Medicine, Morgantown, WV, and colleagues reported their results in Ophthalmic Plastic and Reconstructive Surgery.

The investigators conducted a randomized controlled trial of 60 patients who underwent monitored anesthesia care sedation for oculoplastic procedures from August 2018 to November 2020.

A total of 32 patients were randomized to aromatherapy and 28 to placebo. Anxiety was measured using the State-Trait Anxiety Inventory and visual analog scale for anxiety, and pain was measured with a visual analog scale for pain, the authors recounted.

They reported that the patients randomized to aromatherapy had significantly lower scores for both parameters measured postoperatively. The patient and control scores on the State-Trait Anxiety Inventory state anxiety scale were, respectively, 24.1 and 29.1 and the respective visual analog scale pain scores were 1.9 and 3.2 (p = 0.05 for both comparisons).

In addition, the patients randomized to aromatherapy also had shorter stays in the post-anesthesia care unit compared with the control patients, ie, 57.7 and 79.4 minutes, respectively (p = 0.03).

Chang and colleagues concluded, “The patients who received aromatherapy reported lower postoperative anxiety and pain. Aromatherapy may be a useful adjuvant analgesic and/or anxiolytic for patients undergoing oculoplastic procedures with monitored anesthesia care sedation.”

Reference
  1. Chang M, Schaefer J, Leonard A, et al. The effect of aromatherapy on anxiety and pain in patients undergoing oculoplastic surgery. Ophthalmic Plast Reconstr Surg. 2024;40:677-680; DOI: 10.1097/IOP.0000000000002692
Related Videos
Arun Gulani, MD: How the Gni instrument enhances precision and control in cataract surgery
EyeCon 2024: Peter J. McDonnell, MD, marvels on mentoring, modern technology, and ophthalmology’s future
EyeCon Co-chair Oluwatosin U. Smith, MD: Passion for Research and Education Drives Her Commitment to Ophthalmology
Dr. SriniVas Sadda Discusses Vision for ARVO as New President: Collaboration, Funding Challenges, and Impact of Annual Meetings
Highlights from the 18th Annual Controversies in Modern Eye Care Symposium: Arjan Hura, MD, on Refractive Surgery, Retina Care, and Record Attendance
ASCRS 2024: ViaLase Updates on Nonincisional Glaucoma Treatment Targeting Trabecular Meshwork
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
© 2024 MJH Life Sciences

All rights reserved.